Pharmaceutical ingredients, including slow-absorbing insulin mixtures; containers; suspensions, including their composition and formulation; for the treatment or prevention of insulin deficiency-related diseases, such as diabetes; and a toolkit.

摘要

The pharmaceutical ingredients include: an insulin compound with a plasma level of at least 3 days; a container; a suspension including the ingredients and the preparation method thereof; a kit for treating or preventing diseases related to insulin deficiency, such as diabetes mellitus.